Greenland Energy receives Nasdaq notice over board independence; listing continues
Greenland Energy Company received a Nasdaq letter after director Roderick McIllree resigned on October 20, 2026, leaving it out of compliance with Nasdaq's majority independent director and audit committee requirements. The company says it appointed Melanie Furlan to the audit committee on October 27, 2026, curing the audit committee deficiency, and its common stock and warrants remain listed. The company must still regain majority independence within the cure period, which runs to the earlier of its next annual meeting or October 20, 2027, with an April 19, 2027 deadline if that meeting occurs before then.
Key points
- Director Roderick McIllree resigned October 20, 2026, triggering the non-compliance.
- Nasdaq letter dated October 28, 2026 set a cure period ending the earlier of the next annual meeting or October 20, 2027.
- Audit committee deficiency cured October 27, 2026 by appointing Melanie Furlan; committee now includes Furlan, Scott Wollney and Carol Craig.
- Common stock (GLND) and public warrants (GLNDW) continue trading on the Nasdaq Global Market.
The filing
Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.